It was found that the majority of TTP patients develop autoantibodies that bind to the spacer domain of ADAMTS13, which is crucial for binding and subsequent processing of VWF (14–18). The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.